Skip to main content
Premium Trial:

Request an Annual Quote

Ignyta Receives $1M Loan Facility

NEW YORK (GenomeWeb News) – Autoimmune diagnostics firm Ignyta today said that Silicon Valley Bank has provided it an additional $1 million capital term loan facility.

The new facility is on top of a previous $500,000 facility between the Ignyta and the bank arranged in June 2012. In January, Ignyta raised $5.5 million in Series B financing.

"Ignyta is well-capitalized to execute our ambition of developing an objective biomarker based test to help detect rheumatoid arthritis in its earliest stages," its Co-Founder and CEO Jonathan Lim said in a statement.

Earlier this week, the San Diego-based firm announced it would be working with Leiden University Medical Center to evaluate epigenetic signatures of patients with early synovitis and rheumatoid arthritis.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.